Albert J. Robichaud
2019
Compensation breakdown
| Non-Equity Incentive Plan | $125,606 |
|---|---|
| Option Awards | $1,891,725 |
| Salary | $427,231 |
| Stock Awards | $1,497,485 |
| Other | $10,275 |
| Total | $3,952,322 |
Robichaud received $1.9M in option awards, accounting for 48% of the total pay in 2019.
Robichaud also received $125.6K in non-equity incentive plan, $427.2K in salary, $1.5M in stock awards and $10.3K in other compensation.
Rankings
In 2019, Albert J. Robichaud's compensation ranked 3,035th out of 13,971 executives tracked by ExecPay. In other words, Robichaud earned more than 78.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,035 out of 13,971 | 78th |
Division Manufacturing | 1,099 out of 5,701 | 81st |
Major group Chemicals And Allied Products | 367 out of 2,200 | 83rd |
Industry group Drugs | 301 out of 1,886 | 84th |
Industry Pharmaceutical Preparations | 222 out of 1,398 | 84th |
Pay ratio
| Albert J. Robichaud's Pay | $3,952,322 |
|---|---|
| Median Employee's Pay | $369,650 |
| Pay Ratio | to 1 |
In 2019, the annual total compensation of Albert J. Robichaud was $3,952,322.
The annual total compensation of the median employee at Sage Therapeutics was $369,650.
The ratio of Albert J. Robichaud's pay to the pay of median employee was therefore to one.
Robichaud's colleagues
We found five more compensation records of executives who worked with Albert J. Robichaud at Sage Therapeutics in 2019.
News
April 28, 2022
April 29, 2021
April 29, 2020
April 25, 2019